Article
LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases.
Endocrine pathology - 1 Sept 2018
Pinheiro Dos Santos Maria José Carregosa, Bastos André Uchimura, da Costa Vitor Rodrigues, Delcelo Rosana, Lindsey Susan Chow, Colozza-Gama Gabriel Avelar, Peng Hongzhuang, Rauscher Frank J, Oler Gisele, Cerutti Janete Maria
Abstract excerpt
We previously described that LIM domain containing 2 (LIMD2) overexpression was closely correlated with metastatic process in papillary thyroid carcinoma (PTC). We here evaluated the expression of LIMD2 in a series of non-metastatic and metastatic PTC and their matched lymph node metastases via immunohistochemistry. LIMD2 was expressed in 74 (81%) of primary PTC and 35 (95%) of lymph node metastases. Sub-analysis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
